Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.3M Sell
95,404
-5,344
-5% -$2.52M 0.23% 92
2025
Q4
$42.9M Buy
100,748
+7,794
+8% +$3.34M 0.22% 91
2025
Q3
$44.2M Buy
92,954
+4,989
+6% +$2.36M 0.28% 76
2025
Q2
$41.3M Buy
87,965
+30,678
+54% +$14M 0.32% 64
2025
Q1
$26.3M Sell
57,287
-3,265
-5% -$1.47M 0.28% 79
2024
Q4
$25M Buy
60,552
+23,733
+64% +$10.8M 0.3% 72
2024
Q3
$17.5M Buy
36,819
+19,315
+110% +$8.81M 0.34% 69
2024
Q2
$7.68M Buy
17,504
+15,335
+707% +$6.75M 0.34% 73
2024
Q1
$1.01M Buy
2,169
+1,451
+202% +$628K 0.14% 151
2023
Q4
$269K Buy
+718
New +$283K 0.07% 229

Other funds holding LIN

&Partners's LIN Position: Q1 2026 in Review

&Partners reduced its Linde (LIN) stake by 5.3% in Q1 2026, selling an estimated $2.52M and leaving 95,404 shares worth $47.3M. The position accounts for 0.23% of the portfolio, ranked #92.

&Partners first reported a position in LIN in Q4 2023 and has held it in 10 quarters since. 2,268 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

  • &Partners held 95,404 shares of Linde worth $47.3M as of Q1 2026.
  • &Partners sold 5,344 Linde shares in Q1 2026, an estimated $2.52M.
  • Linde made up 0.23% of &Partners's portfolio in Q1 2026, its #92 holding.
  • &Partners first reported a position in Linde in Q4 2023 and has held it in 10 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.